Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis
NCT00750139
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
707
Enrollment
INDUSTRY
Sponsor class
Conditions
Tinea Pedis
Athlete's Foot
Interventions
DRUG:
NAFT-500
DRUG:
Placebo 2-weeks
DRUG:
Naftin 1%
DRUG:
Placebo 4-weeks
Sponsor
Merz North America, Inc.